(Q35065532)

6 August 2017

1 reference

title

The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease (English)

1 reference

6 August 2017

1 reference

1 reference

Domenic A Sica

1

1 reference

6 August 2017

Todd W B Gehr

series ordinal

2

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

247-254

1 reference

Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Hypertension is not adequately controlled in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Efficacy and tolerability of angiotensin II type 1 receptor antagonists in dialysis patients using AN69 dialysis membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Pharmacokinetics and blood pressure response of losartan in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Renal failure, uncontrollable thirst, and hyperreninemia. Cessation of thirst with bilateral nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Effect of cilazapril on hyperdipsia in hemodialyzed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Does angiotensin II receptor antagonist Losartan suppress drinking behavior in hemodialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Anaemia in dialysis patients as a side-effect of sartanes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Angioedema induced by the angiotensin II blocker losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Angioneurotic edema attributed to the use of losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTS

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.046

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2002.046

1 reference

6 August 2017

1 reference